Glaukos Corporation Glaukos Corporation

Glaukos Corporation

GKOS

Classifica tra le azioni #1986
Glaukos Corporation operates as an ophthalmic medical technology and... Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Prezzo delle azioni
$177.09
Ultima sincronizzazione: 2026-10-21
Capitalizzazione di mercato
$10.45B
Variazione (1 giorno)
1.76%
Variazione (1 anno)
131.10%
Paese
US
Scambia Glaukos Corporation (GKOS)

Categoria

Healthcare
Storico del prezzo dell'azione per Glaukos Corporation (GKOS)
Prezzo di chiusura più alto: $166.80 il 2026-10-01

Prezzo di chiusura più basso: $29.05 il 2015-06-01
Storico del prezzo dell'azione di Glaukos Corporation dal 2015 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 16.37%
2025 -22.38%
2024 97.91%
2023 64.84%
2022 1.09%
2021 -38.87%
2020 24.29%
2019 -5.51%
2018 133.10%
2017 -22.73%
2016 38.93%
2015 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$100.56 -21.41%
US
$93.07 -2.95%
IE
$297.13 -23.49%
US
$44.47 -57.18%
US
$46.69 -18.50%
DE